ZHENGWEI GROUP (02147): The financial year end has been changed to June 30th.
The Zhengwei Group (02147) announced that the board of directors has decided to change the company's fiscal year-end from December 31st...
ZHENGWEI GROUP (02147) announced that the Board of Directors has decided to change the company's financial year-end date from December 31 to June 30, effective immediately. Therefore, the company's next financial year-end date will be June 30, 2025, and the next set of audited financial statements to be published by the group will cover the eighteen-month period from January 1, 2024, to June 30, 2025.
Related Articles
TSUGAMI CHINA (01651) spent 2.479 million Hong Kong dollars to repurchase 80,000 shares on September 17th.
Jiangsu Hengrui Pharmaceuticals (01276) recently received acceptance of its application for market approval for the new indication of injection rituximab in combination with trastuzumab, and has been included in the priority review process.
On September 17th, HAOHAI BIOTEC (06826) spent HK$515,200 to repurchase 18,400 shares.
TSUGAMI CHINA (01651) spent 2.479 million Hong Kong dollars to repurchase 80,000 shares on September 17th.
Jiangsu Hengrui Pharmaceuticals (01276) recently received acceptance of its application for market approval for the new indication of injection rituximab in combination with trastuzumab, and has been included in the priority review process.
On September 17th, HAOHAI BIOTEC (06826) spent HK$515,200 to repurchase 18,400 shares.
